Embo Registry; National Registry for Artery Embolization
Launched by VASCULAR SOLUTIONS OF NORTH CAROLINA · Jun 21, 2024
Trial Information
Current as of April 27, 2025
Recruiting
Keywords
ClinConnect Summary
The Embo Registry is a study designed to learn more about how effective a treatment called Artery Embolization is for managing chronic pain, particularly in patients suffering from osteoarthritis and other localized pain conditions. This study looks at both past and current patients to see if this procedure can help reduce pain and improve overall quality of life.
If you are over 18 years old and have had an Artery Embolization procedure to treat chronic pain, you might be eligible to participate. There are no specific exclusions, so most individuals who meet the age requirement and have undergone the treatment can join. Participants in this study can expect to provide information about their pain levels and life improvements after the procedure, helping researchers understand how well this treatment works in real-life situations. Your involvement could contribute valuable insights into managing chronic pain for many people.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • \> 18 years of age undergone artery embolization interventions for the treatment of chronic pain due to osteoarthritis or other diagnoses that cause localized pain.
- Exclusion Criteria:
- • None
About Vascular Solutions Of North Carolina
Vascular Solutions of North Carolina is a pioneering clinical trial sponsor dedicated to advancing vascular health through innovative research and development. With a focus on enhancing patient outcomes, the organization conducts robust clinical trials that evaluate cutting-edge medical devices and therapies. Committed to upholding the highest standards of ethics and compliance, Vascular Solutions collaborates with leading healthcare professionals and institutions to ensure the safety and efficacy of its products. By striving for excellence in clinical research, the organization aims to contribute significantly to the field of vascular medicine and improve the quality of care for patients across diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cary, North Carolina, United States
Winchester, Tennessee, United States
Patients applied
Trial Officials
Siddhartha Rao, MD
Principal Investigator
Vascular Solutions of North Carolina
Amer Iqbal
Study Director
Vascular Solutions of North Carolina
Meaghan Thomas, CCRP
Study Chair
Vascular Solutions of North Carolina
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported